Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction

American Journal of Cardiology

Volumn 109, Issue 12, 2012, Pages 1694-1699

  Mahajan, Nitin ^a   Ference, Brian A ^a   Arora, Natasha ^a   Madhavan, Ramesh ^b   Bhattacharya, Pratik ^b   Sudhakar, Rajeev ^a   Sagar, Amit ^a   Wang, Yun ^a   Sacks, Frank ^c,d   Afonso, Luis ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; BODY MASS; CARDIOVASCULAR RISK; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; PRIORITY JOURNAL; REVIEW; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84861622683     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.02.010     Document Type: Article

References (28)

1. Emerging Risk Factors Collaboration Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 2009 1993 2000
2. M. Benn, B.G. Nordestgaard, G.B. Jensen, A. Tybjaerg-Hansen Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study Arterioscler Thromb Vasc Biol 27 2007 661 670
3. C. Kuo-Liong, F.C. Sung, H.C. Hsu, T.C. Su, R.S. Lin, L.T. Yee Apolipoprotein A-I and B and stroke events in a community-based cohort in Taiwan Stroke 33 2002 39 44
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
5. F.M. Sacks, M.A. Pfeffer, L. Moye', L.E. Brown, P. Hamm, T.G. Cole, C.M. Hawkins, E. Braunwald Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE) Am J Cardiol 68 1991 1436 1446
6. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, T.G. Cole, L. Brown, J.W. Warnica, J.M. Arnold, C.C. Wun, B.R. Davis, E. Braunwald Cholesterol and Recurrent Events Trial Investigators The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001 1009
7. W.T. Friedewald, R.I. Levy, D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
8. J.P. Klein, L. Melvin Survival Analysis: Techniques for Censored and Truncated Regression 1997 Springer-Verlag New York, New York 543
9. R.C. Boston, A.E. Sumner Stata: a statistical analysis system for examining biomedical data Adv Exp Med Biol 537 2003 353 369
10. J. Herlitz, J. Holm, M. Peterson, B.W. Karlson, M.H. Evander, L. Erhardt LoWASA Study Group Factors associated with development of stroke long-term after myocardial infarction: experiences from the LoWASA trial J Intern Med 257 2005 201 207
11. R.C. Kaplan, S.R. Heckbert, C.D. Furberg, B.M. Psaty Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction J Clin Epidemiol 55 2002 654 664
12. U.K. Sampson, M.A. Pfeffer, J.J. McMurray, Y. Lokhnygina, H.D. White, S.D. Solomon VALIANT Trial Investigators Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT trial Eur Heart J 28 2007 685 691
13. H. Iso, D.R. Jacobs Jr, D. Wentworth, J.D. Neaton, J.D. Cohen Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial N Engl J Med 320 1989 904 910
14. N. Koren-Morag, D. Tanne, E. Graff, U. Goldbourt Low- and high density lipoprotein cholesterol and ischemic cerebrovascular disease: the Bezafibrate Infarction Prevention registry Arch Intern Med 62 2002 993 999
15. E. Shahar, L. Chambless, W.D. Rosamond, L. Boland, C.M. Ballantyne, P.G. McGovern, A.R. Sharrett Plasma lipid profile and incident ischemic stroke The Atherosclerosis Risk in Communities (ARIC) study Stroke 34 2003 623 631
16. M. Woodward, F. Barzi, V. Feigin, D. Gu, R. Huxley, K. Nakamura, A. Patel, S. Ho, K. Jamrozik Asia Pacific Cohort Studies Collaboration Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region Eur Heart J 28 2007 2653 2660
17. O.Y. Bang, J.L. Saver, D.S. Liebeskind, S. Pineda, B. Ovbiagele Association of serum lipid indices with large artery atherosclerotic stroke Neurology 70 2008 841 847
18. E. Lindenstrom, G. Boysen, J. Nyboe Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study BMJ 309 1994 11 15
19. L.A. Simons, J. Simons, Y. Friedlander, J. McCallum Cholesterol and other lipids predict coronary heart disease and ischemic stroke in the elderly, but only in those below 70 years Atherosclerosis 159 2001 201 208
20. H.N. Hodis Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis Circulation 99 1999 2852 2854
21. M.L. Gronholdt, B.G. Nordestgaard, T.G. Nielsen, H. Sillesen Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins Stroke 27 1996 2166 2172
22. C. Zheng, C. Khoo, J. Furtado, F.M. Sacks Apolipoprotein CIII and the metabolic basis for hypertriglyceridemia and the dense low protein lipoprotein phenotype Circulation 121 2010 1722 1734
23. A. Kawakami, M. Aikawa, P. Alcaide, F.W. Luscinskas, P. Libby, F.M. Sacks Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells Circulation 114 2006 681 687
24. T. Kurth, B.M. Everett, J.E. Buring, C.S. Kase, P.M. Ridker, J.M. Gaziano Lipid levels and the risk of ischemic stroke in women Neurology 68 2007 556 562
25. M.A. Albert, R.J. Glynn, F.A. Fonseca, A.J. Lorenzatti, K.C. Ferdinand, J.G. MacFadyen, P.M. Ridker Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial Am Heart J 162 2011 106 114
26. P.S. Sever, B. Dahlöf, N.R. Poulter, H. Wedel, G. Beevers, M. Caulfield, R. Collins, S.E. Kjeldsen, A. Kristinsson, G.T. McInnes, J. Mehlsen, M. Nieminen, E. O'Brien, J. Ostergren ASCOT Investigators Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial Lancet 361 2003 1149 1158
27. J.F. Plehn, B.R. Davis, F.M. Sacks, J.L. Rouleau, M.A. Pfeffer, V. Bernstein, T.E. Cuddy, L.A. Moyé, L.B. Piller, J. Rutherford, L.M. Simpson, E. Braunwald Reduction of stroke incidence after myocardial infarction The Cholesterol and Recurrent Events Study Circulation 99 1999 216 223
28. R. De Caterina, M. Scarano, R. Marfisi, G. Lucisano, F. Palma, A. Tatasciore, R. Marchioli Insights from a meta-analysis of randomized controlled trials J Am Coll Cardiol 55 2010 198 211